These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11006125)

  • 1. Neuroendocrine-specific protein C, a marker of neuronal differentiation, is reduced in brain of patients with Down syndrome and Alzheimer's disease.
    Kim SH; Yoo BC; Broers JL; Cairns N; Lubec G
    Biochem Biophys Res Commun; 2000 Sep; 276(1):329-34. PubMed ID: 11006125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.
    Greber S; Lubec G; Cairns N; Fountoulakis M
    Electrophoresis; 1999; 20(4-5):928-34. PubMed ID: 10344268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.
    Yoo BC; Fountoulakis M; Cairns N; Lubec G
    Electrophoresis; 2001 Jan; 22(1):172-9. PubMed ID: 11197169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease.
    Lumbreras M; Baamonde C; Martínez-Cué C; Lubec G; Cairns N; Sallés J; Dierssen M; Flórez J
    Amino Acids; 2006 Nov; 31(4):449-56. PubMed ID: 16583316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.
    Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M
    Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The unfolded protein response affects neuronal cell cycle protein expression: implications for Alzheimer's disease pathogenesis.
    Hoozemans JJ; Stieler J; van Haastert ES; Veerhuis R; Rozemuller AJ; Baas F; Eikelenboom P; Arendt T; Scheper W
    Exp Gerontol; 2006 Apr; 41(4):380-6. PubMed ID: 16564150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of molecular chaperones in brain of patients with Down syndrome.
    Yoo BC; Vlkolinsky R; Engidawork E; Cairns N; Fountoulakis M; Lubec G
    Electrophoresis; 2001 Apr; 22(6):1233-41. PubMed ID: 11358150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the relation of herpes simplex virus type 1 to Down syndrome and Alzheimer's disease.
    Cheon MS; Bajo M; Gulesserian T; Cairns N; Lubec G
    Electrophoresis; 2001 Feb; 22(3):445-8. PubMed ID: 11258753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic signatures and aberrations of mouse embryonic stem cells containing a single human chromosome 21 in neuronal differentiation: an in vitro model of Down syndrome.
    Kadota M; Nishigaki R; Wang CC; Toda T; Shirayoshi Y; Inoue T; Gojobori T; Ikeo K; Rogers MS; Oshimura M
    Neuroscience; 2004; 129(2):325-35. PubMed ID: 15501590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain.
    Su JH; Kesslak JP; Head E; Cotman CW
    Acta Neuropathol; 2002 Jul; 104(1):1-6. PubMed ID: 12070657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
    Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS
    Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
    Albasanz JL; Dalfó E; Ferrer I; Martín M
    Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased phosphoglycerate kinase in the brains of patients with Down's syndrome but not with Alzheimer's disease.
    Labudova O; Kitzmueller E; Rink H; Cairns N; Lubec G
    Clin Sci (Lond); 1999 Mar; 96(3):279-85. PubMed ID: 10029564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.
    Cataldo AM; Petanceska S; Terio NB; Peterhoff CM; Durham R; Mercken M; Mehta PD; Buxbaum J; Haroutunian V; Nixon RA
    Neurobiol Aging; 2004; 25(10):1263-72. PubMed ID: 15465622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome.
    Head E; Azizeh BY; Lott IT; Tenner AJ; Cotman CW; Cribbs DH
    Neurobiol Dis; 2001 Apr; 8(2):252-65. PubMed ID: 11300721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular misreading: the frequency of dinucleotide deletions in neuronal mRNAs for beta-amyloid precursor protein and ubiquitin B.
    Gerez L; de Haan A; Hol EM; Fischer DF; van Leeuwen FW; van Steeg H; Benne R
    Neurobiol Aging; 2005 Feb; 26(2):145-55. PubMed ID: 15582744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroanatomy of Down syndrome in vivo: a model of preclinical Alzheimer's disease.
    Teipel SJ; Hampel H
    Behav Genet; 2006 May; 36(3):405-15. PubMed ID: 16485178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
    Mehta PD; Capone G; Jewell A; Freedland RL
    J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased protein levels of serotonin transporter in frontal cortex of patients with Down syndrome.
    Gulesserian T; Engidawork E; Cairns N; Lubec G
    Neurosci Lett; 2000 Dec; 296(1):53-7. PubMed ID: 11099832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.